HRI is an internationally recognised medical research institute, with global collaborations.
It is a unique time to join HRI. The next few years have the potential to be transformative, with developments such as the $150 million Cardiovascular Disease Research Capacity Building Program backed by the NSW government in 2018, and HRI’s strong fundraising capabilities, which provide a reliable and independent source of long-term funding.
Our success comes down to our people. From our scientists and researchers, to our operations and fundraising staff – they all play key roles in ensuring HRI’s place as a world-leading medical research institute.
HRI is a centre of excellence in cardiovascular medical research affiliated with the Royal Prince Alfred Hospital and The University of Sydney, located over two locations in Eliza Street, Newtown and the Charles Perkins Centre (CPC) at The University of Sydney. For over 30 years, HRI has been one of Australia's leading research organisations working to detect, prevent and treat heart disease. Through our research, HRI has made significant findings that have changed the way we live with and treat cardiovascular disease.
HRI is seeking a post-doctoral Molecular Biologist to contribute to innovative and collaborative research programs with a focus on cardiovascular genetic approaches to better understand the biology of the vasculature. The position would be within the Atherosclerosis and Vascular Remodelling (AVRG) group, that uses genetic mouse models, lineage tracing, clonal analysis and primary cell culture to elucidate mechanisms. It is creating new murine models to mimic vascular disease in humans to be used to assess progression of CVD, and to assess therapeutic targets that promote regression.
The Molecular Biologist would also support other groups in HRI in collaborative projects that require particular expertise in genetic techniques.
Find out more and apply.